Clinical Trial Results:
A Phase IIa Exploratory Study of OCZ103-OS in Combination with Platinum-Gemcitabine based Doublet First Line Therapy in Stage IV Non-Small Cell Lung Cancer (NSCLC) Patients
Summary
|
|
EudraCT number |
2012-001812-50 |
Trial protocol |
PL |
Global completion date |
15 Jul 2013
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
No
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
No
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
No
|
Results information
|
|
Results version number |
v1(current) |
This version publication date |
20 Nov 2021
|
First version publication date |
20 Nov 2021
|
Other versions |
|
Summary report(s) |
NSCLC_OCZ103OS_Manuscript_v3.0_31MAR2016_Clean |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.